BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Mazziotta C, Rotondo JC, Lanzillotti C, Campione G, Martini F, Tognon M. Cancer biology and molecular genetics of A3 adenosine receptor. Oncogene 2021. [PMID: 34750517 DOI: 10.1038/s41388-021-02090-z] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 11.0] [Reference Citation Analysis]
Number Citing Articles
1 Kaur T, Weadick B, Mace TA, Desai K, Odom H, Govindarajan R. Nucleoside transporters and immunosuppressive adenosine signaling in the tumor microenvironment: Potential therapeutic opportunities. Pharmacology & Therapeutics 2022;240:108300. [DOI: 10.1016/j.pharmthera.2022.108300] [Reference Citation Analysis]
2 Elaskalani O, Gilmore G, Hagger M, Baker RI, Metharom P. Adenosine 2A Receptor Activation Amplifies Ibrutinib Antiplatelet Effect; Implications in Chronic Lymphocytic Leukemia. Cancers 2022;14:5750. [DOI: 10.3390/cancers14235750] [Reference Citation Analysis]
3 Muñoz-lópez S, Sánchez-melgar A, Martín M, Albasanz JL. Resveratrol enhances A1 and hinders A2A adenosine receptors signaling in both HeLa and SH-SY5Y cells: Potential mechanism of its antitumoral action. Front Endocrinol 2022;13. [DOI: 10.3389/fendo.2022.1007801] [Reference Citation Analysis]
4 Wang J, Du L, Chen X. Adenosine signaling: Optimal target for gastric cancer immunotherapy. Front Immunol 2022;13:1027838. [DOI: 10.3389/fimmu.2022.1027838] [Reference Citation Analysis]
5 Park S, Ahn Y, Kim Y, Roh EJ, Lee Y, Han C, Yoo HM, Yu J. Design, Synthesis and Biological Evaluation of 1,3,5-Triazine Derivatives Targeting hA1 and hA3 Adenosine Receptor. Molecules 2022;27:4016. [DOI: 10.3390/molecules27134016] [Reference Citation Analysis]
6 Rotondo JC, Martini F, Maritati M, Caselli E, Gallenga CE, Guarino M, De Giorgio R, Mazziotta C, Tramarin ML, Badiale G, Tognon M, Contini C. Advanced Molecular and Immunological Diagnostic Methods to Detect SARS-CoV-2 Infection. Microorganisms 2022;10:1193. [PMID: 35744711 DOI: 10.3390/microorganisms10061193] [Cited by in Crossref: 5] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
7 Fishman P. Drugs Targeting the A3 Adenosine Receptor: Human Clinical Study Data. Molecules 2022;27:3680. [PMID: 35744805 DOI: 10.3390/molecules27123680] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
8 Aldawsari HM, Singh S, Alhakamy NA, Bakhaidar RB, Halwani AA, Sreeharsha N, Badr-eldin SM. Adenosine Conjugated Docetaxel Nanoparticles—Proof of Concept Studies for Non-Small Cell Lung Cancer. Pharmaceuticals 2022;15:544. [DOI: 10.3390/ph15050544] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Mazziotta C, Lanzillotti C, Gafà R, Touzé A, Durand MA, Martini F, Rotondo JC. The Role of Histone Post-Translational Modifications in Merkel Cell Carcinoma. Front Oncol 2022;12:832047. [PMID: 35350569 DOI: 10.3389/fonc.2022.832047] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
10 Lemmerhirt JP, Isaak A, Liu R, Kock M, Daniliuc CG, Jacobson KA, Heitman LH, Junker A. Development of Bicyclo[3.1.0]hexane-Based A3 Receptor Ligands: Closing the Gaps in the Structure–Affinity Relationships. Molecules 2022;27:2283. [DOI: 10.3390/molecules27072283] [Reference Citation Analysis]
11 Zhulai G, Oleinik E, Shibaev M, Ignatev K. Adenosine-Metabolizing Enzymes, Adenosine Kinase and Adenosine Deaminase, in Cancer. Biomolecules 2022;12:418. [DOI: 10.3390/biom12030418] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 5.0] [Reference Citation Analysis]
12 Rotondo JC, Mazziotta C, Lanzillotti C, Stefani C, Badiale G, Campione G, Martini F, Tognon M. The Role of Purinergic P2X7 Receptor in Inflammation and Cancer: Novel Molecular Insights and Clinical Applications. Cancers (Basel) 2022;14:1116. [PMID: 35267424 DOI: 10.3390/cancers14051116] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 9.0] [Reference Citation Analysis]
13 Oton-Gonzalez L, Mazziotta C, Iaquinta MR, Mazzoni E, Nocini R, Trevisiol L, D'Agostino A, Tognon M, Rotondo JC, Martini F. Genetics and Epigenetics of Bone Remodeling and Metabolic Bone Diseases. Int J Mol Sci 2022;23:1500. [PMID: 35163424 DOI: 10.3390/ijms23031500] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
14 Rotondo JC, Mazziotta C, Lanzillotti C, Tognon M, Martini F. Epigenetic Dysregulations in Merkel Cell Polyomavirus-Driven Merkel Cell Carcinoma. Int J Mol Sci 2021;22:11464. [PMID: 34768895 DOI: 10.3390/ijms222111464] [Cited by in Crossref: 9] [Cited by in F6Publishing: 10] [Article Influence: 9.0] [Reference Citation Analysis]